References Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al
Efficiency: This delivery method is designed to bypass the traditional "saturation points" of standard supplements, allowing more of the nutrient to reach your bloodstream and stay active longer
With the monoclonal antibodies targeting amyloid, we got the first breakthrough. Biogen, the maker of aducanumab, later pulled it from the market to focus on a second drug, which is now one of two such antibodies available in the US
A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice
There was no blinding, there was no control group, and there were no validated questionnaires
Natural IGF-1 gets grabbed almost immediately by binding proteins that shuttle it around and limit its activity